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 Ground-glass opacity of the lung is often demonstrated on 
high-resolution CT (HRCT) in various diffuse lung diseases. 
Ground-glass opacity generally results from minimal 
thickening of the alveolar interstitium or partial filling in the 
alveolar spaces. We classify diffuse infiltrative lung diseases 
into two clinical categories, namely, noninfectious and 
infectious lung disease. In noninfectious lung disease, al-
though ground-glass opacity can be observed as an isolated 
finding, it is commonly observed to be combined with other 
findings such as centrilobular micronodules, interlobular 
septal thickening, and cystic air-spaces. These associated 
findings may be important for the differential diagnosis. 
Ground-glass opacity may also be seen as a consequence of 
increased capillary blood volume in redistribution of blood 
flow. This condition of hemodynamic origin is observed in 
chronic obstructive pulmonary disease, airway disease, and 
vascular lung disease. Although ground-glass opacity is a 
nonspecific finding, it can suggest a specific diagnosis in 
certain clinical circumstances or indicate a potentially 
treatable disease. Therefore, accurate recognition and 
differential diagnosis of ground-glass opacity are important.
ble, if the underlying disorder is treated early. Therefore, 
accurate diagnosis of underlying disorders in their early 
stages is important. Because ground-glass opacity per se is 
a nonspecific finding on HRCT, associated findings may be 
important for the differential diagnosis. This article deals 
with various causes of ground-glass opacity and provides a 
guide to the differential diagnosis of the diseases that can 
produce this finding. We will also describe some important 
pitfalls in evaluating ground-glass opacity on HRCT.
Definition of Ground-Glass Opacity 
 Ground-glass opacity can be defined by four main 
criteria : (1) areas of hazy and amorphous increased lung 
density ; (2) no obscuration of the underlying vascular 
markings and bronchial walls ; (3) identification on 
HRCT sections ; and (4) photographed with wide window 
settings [3].
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Introduction 
  'Ground -glass opacity' is defined as nonspecific in-
creased density of the pulmonary parenchyma that is not 
associated with obscuration of the underlying pulmonary 
vessels on high-resolution CT (HRCT) [1-4]. This appear-
ance is caused by a change in the relative proportions of air 
in the alveolar space and thickening of the alveolar 
interstitium that is out of the resolution capabilities of 
HRCT. In contrast to ground-glass opacity, increased lung 
density with obscuration of the underlying pulmonary 
vessels is referred to as `consolidation' [1]. 
 Generally, ground-glass opacity is potentially reversi-
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Causes of Ground-Glass Opacity 
 Lung density results from the relative proportions of the 
blood, air, extravascular water, and pulmonary tissue [3]. 
Generally, increased lung density histologically reflects 
thickening of the alveolar walls and septal interstitium or 
the filling of fluid, cells, or amorphous material in the 
alveolar spaces. Increased lung density can be classified 
into 'ground-glass opacity' and `consolidation'. Ground-
glass opacity reflects the presence of minimal thickening 
of the alveolar interstitium or the presence of fluid, cells, 
or amorphous material partially filling the alveolar spaces 
(Fig. 1) [1-41. If there are more materials in the alveolar 
spaces or more thickening of the interstitium and less air 
in the alveolar space, the condition is increased lung 
density of higher degree and referred to as `consolidation' 
on HRCT. Therefore, ground-glass opacity and consolida-
tion are combined to varying degrees in a large number of 
lung diseases. The HRCT findings in some diffuse lung 
diseases are predominated by ground-glass opacity, and in 
others by consolidation (Table 1). In this article, we
Normal alveoli A. Thickening of the 
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Fig. 1. Anatomic diagram of ground-glass opacity (modified from figure of reference 2) 
A. Thickening of the alveolar interstitium occurs for cellular infiltration or fibrosis, and decreases the amount of airspaces. 
B. Alveolar spaces can be partially filled with cellular debris, fluid, or amorphous material. 
In the states of A or B, these events are not individually resolvable by HRCT. The change in proportions between air in the 
alveolar spaces and thickening of the alveolar interstitium leads to an increase of lung density on HRCT. It is expressed as a 
"ground -glass opacity" .
Table 1. Classification by predominant findings of diffuse 
lung diseases with ground-glass opacity and/or consolida-
tion
1. Ground-glass opacity dominant 
     Hypersensitivity pneumonitis 
     Respiratory bronchiolitis (-interstitial lung disease) 
     Alveolar proteinosis 
     Usual interstitial pneumonia (UIP) 
     Desquamative interstitial pneumonia 
     Nonclassifable interstitial pneumonia 
     Lymphocytic interstitial pneumonia 
     Sarcoidosis 
     Atypical pneumonia 
       (e.g. Pneumocystis carinii pneumonia) 
     Drug induced pneumonitis 
     Redistribution of pulmonary blood flow 
       (e.g. chronic thromboembolic disease) 
2. Consolidation dominant 
     Bronchiolitis obliterans with organizing pneumonia 
     Eosinophilic pneumonia 
     Bacterial pneumonia 
     Radiation pneumonitis 
3. Ground-glass opacity and consolidation 
     Acute interstitial pneumonia 
      (Diffuse alveolar damage) 
     Accelerated deterioration of UIP 
      (Diffuse alveolar damage) 
     Bronchioloalveolar carcinoma 
     Pulmonary edema 
     Pulmonary hemorrhage 
     Metastatic calcification
mainly discuss the diseases in which ground-glass opacity 
is more predominant than consolidation on HRCT. We 
divide diffuse infiltrative lung diseases into two clinical 
categories, namely, noninfectious and infectious lung 
disease. 
 Increased lung density may also result from an increase 
in pulmonary capillary blood volume (hyperperfusion). It 
causes diffuse or focal ground-glass opacity on HRCT. 
Because the change of lung density due to increased pulmo-
nary blood volume is commonly minimal, however, it may 
easily be overlooked on HRCT. Regional alterations in 
pulmonary blood volume are common hemodynamic 
factors shared by various clinical situations [3, 5-81. 
Ground-glass opacity of hemodynamic origin is also 
discussed in this article.
Ground-Glass Opacity in Noninfectious 
Lung Disease 
 Ground-glass opacity has been known in various 
noninfectious lung diseases, including alveolar proteinosis, 
usual interstitial pneumonia (UIP), desquamative inter-
stitial pneumonia (DIP), lymphocytic interstitial pneumo-
nia (LIP), bronchiolitis obliterans with organizing 
pneumonia (BOOP), eosinophilic pneumonia, hypersensi-
tivity pneumonitis (HP), respiratory bronchiolitis, sar-
coidosis, radiation pneumonitis/fibrosis, metastatic 
calcification, and alveolar microlithiasis. 
 A large number of noninfectious lung diseases begin with
an accumulation of inflammatory cells in the alveolar 
septa and air-spaces and often culminate in severe fibrosis 
of the interstitium. Ground-glass opacity often reflects 
mild parenchymal alterations and may provide informa-
tion about disease activity and prognosis. 
 The best known significance of ground-glass opacity is 
to reflect an active inflammatory process, representing the 
acute phase of lung injury referred to as alveolitis. In acute 
phase, the main pathologic features are observed to 
involve both the alveolar interstitium and the air-spaces. 
Pathologic specimen shows thickening of the alveolar 
interstitium and incomplete filling of the alveolar spaces 
with inflammatory cells, cellular debris, and edema [3]. 
Ground-glass opacity on HRCT may sometimes reflect 
isolated inflammation of alveolar interstitium without 
air-space filling. In this phase, corticosteroid treatment is 
useful for a large number of these diseases. 
 Ground-glass opacity may also result from chronic 
changes that occur following acute lung injury in the 
absence of complete healing corresponding to lung fibrosis 
with or without lung distortion. The fibrotic reaction 
associated with residual alveolar infiltrates and debris 
leads to reduction of the amount of air in the alveolar 
spaces. Healing by fibrosis leads to formation of dense 
areas of collagen interspersed with parenchymal destruc-
tion. The resultant cystic and destructive changes consti-
tute the hallmarks of late-phase lung disease (pulmonary 
fibrosis). When cystic changes (honeycombing) are within 
the resolution capabilities of HRCT, a classical `macro-
scopic' honeycombing appears. When cystic changes are 
too small to be detected by HRCT, volume averaging of 
tiny cysts that characterize the microcystic (`micro-
scopic') honeycombing may lead to ground-glass opacity.
Bronchi and bronchioles in the regions of lung distortion 
appear dilated and deformed secondary to the underlying 
destructive process, resulting in traction bronchiectasis or 
bronchiolectasis [9], another hallmark of pulmonary 
fibrosis. 
 Although ground-glass opacity can be observed as an 
isolated HRCT finding, it is more commonly observed to 
be combined with other HRCT findings. The most frequent 
associations are micronodular pattern and cystic air-
spaces [3]. Micronodular pattern associated with ground-
glass opacity usually reflects peribronchiolar or 
bronchiolar abnormalities and is demonstrated in 
centrilobular distribution. Cystic air-spaces associated 
with ground-glass opacity often reveal honeycombing 
(honeycomb cysts). Reticular opacities may also be 
combined with ground-glass opacity and they reflect 
fibrosis. Thus, we classify the ground-glass opacity seen in 
noninfectious lung diseases on the basis of the associated 
HRCT findings (Table 2).
1. Isolated Ground-Glass Opacity 
 The conditions showing isolated ground-glass opacities 
include mild inflammation or fibrosis of alveolar 
interstitium (increased cellularity of the alveolar 
interstitium) and partial filling of the alveolar spaces 
with cells or fluid. 
 Desquamative interstitial pneumonia (DIP) is charac-
terized histologically by the presence of mild inflamma-
tion and fibrosis of the alveolar septa with relative 
preservation of the alveolar structures, and the presence of 
cells (alveolar macrophages) within the alveolar spaces 
[10, 111. The areas of ground-glass opacity are predomi-
Table 2. Classification by combination with other findings in noninfectious lung disease 
 1. Isolated Ground-Glass Opacity 
         Desquamative interstitial pneumonia 
        Nonclassifable interstitial pneumonia 
        Radiation pneumonitis (without fibrosis) 
         Pulmonary hemorrhage 
 2. Ground-Glass Opacity Combined with Other Findings 
     1) Centrilobular micronodules with ground-glass opacity 
        Respiratory bronchiolitis (- interstitial lung disease) 
        Hypersensitivity pneumonitis (acute or subacute stage) 
    2) Interlobular septal thickening within ground-glass opacity 
         Alveolar proteinosis 
         Pulmonary edema (interstitial edema) 
     3) Cystic air-spaces with ground-glass opacity 
        Usual interstitial pneumonia 
        Accelerated deterioration of UIP (Diffuse alveolar damage) 
        Hypersensitivity pneumonitis (chronic stage) 
         Various end-stage lungs (e.g. sarcoidosis)
        Pulmonary emphysema (redistribution of pulmonary blood flow)
nantly located in the posterior, basal, and peripheral 
regions on HRCT [111. Because interstitial fibrosis is mild 
or absent, the alteration in the structure of the lung 
parenchyma is commonly absent. 
 A recently identified new entity termed nonclassifiable 
interstitial pneumonia (NCIP) or nonspecific interstitial 
pneumonia has been reported in pathological literatures 
[12]. In comparison with UIP, fibrosis is uncommon in 
NCIP. On HRCT, the areas of ground-glass opacity and 
consolidation may be combined without lung distortion 
and honeycombing [13]. 
 Radiation pneumonitis without fibrosis may be demon-
strated as an isolated ground-glass opacity. It usually 
corresponds to radiation field and pathologically reflects 
to diffuse alveolar damage (DAD). Pulmonary hemor-
rhage may also be depicted as an isolated ground-glass 
opacity on HRCT.
consolidation on HRCT reflects alveolar filling by cells 
(such as lymphocytes) or obstructive pneumonitis [171. 
The nodular appearance correlates with the presence of 
alveolitis, interstitial infiltrates, small granulomas, and 
cellular bronchiolitis : histologic abnormalities are usu-
ally most severe in a peribronchiolar distribution [181. 
These peribronchiolar abnormalities cause obstructive 
change to the small airway, and the areas of airtrapping
2. Ground-Glass Opacity Combined with Other Findings 
1) Centrilobular micronodules with ground-glass opacity 
 Centrilobular micronodules result from inflammation 
or fibrosis of the peribronchial interstitium and bronchial 
wall, and bronchiolar dilatation [2, 14, 15]. Differential 
diagnosis of centrilobular micronodules includes endo-
bronchial dissemination of infection and neoplasm such as 
pulmonary tuberculosis and bronchioloalveolar carcinoma. 
 Respiratory bronchiolitis is referred to as "smokers' 
bronchiolitis" [14-161. It mainly involves the respiratory 
bronchioles and is characterized by mild chronic inflamma-
tion of the bronchioles associated with prominent accumu-
lation of pigmented macrophages in the respiratory 
bronchioles and adjacent alveolar ducts and alveoli [14-
18]. The vast majority of cases produce no clinical symp-
toms. Occasionally, however, it may be severe enough to 
produce clinical abnormalities, a condition referred to as 
respiratory bronchiolitis-interstitial lung disease [12, 15]. 
Ground-glass opacity associated with centrilobular ill-
defined nodules are seen in respiratory bronchiolitis (Fig. 
2) [14-18]. Only the upper lung zones may be involved, but 
the abnormality can be diffuse [18]. The prognosis of 
patients with respiratory bronchiolitis is good ; progres-
sion to pulmonary fibrosis or respiratory failure has not 
been reported during follow-up periods of several years. 
 Acute or subacute stage of hypersensitivity pneumonitis 
(HP) can also be combined with centrilobular micro-
nodular opacities (Fig. 3). Consolidation may be combined 
with ground-glass opacity. Ground-glass opacity and 
consolidation are often patchy in multilobular distribu-
tion and they are sharply demarcated by relatively spared 
regions, making the so-called geographic pattern (Fig. 4). 
This finding is typical in HP, but a large number of diffuse 
infiltrative lung diseases may also show similar findings. 
In acute or subacute stage, ground-glass opacity or
Fig. 2. Suspected respiratory bronchiolitis. III -defined 
centrilobular nodules associated with diffuse ground-glass 
opacity are depicted in left upper lobe. These findings pre-
dominantly distributed in bilateral upper lobes on HRCT.
Fig. 3. III -defined centrilobular nodules associated with 
diffuse ground-glass opacity is depicted in a patient with 
acute hypersensitivity pneumonitis. Relatively low attenua-
tion indicating spared lung region of lobular units is also 
demonstrated (arrow).
predominates in BOOP, reflecting organizing pneumonia.
Fig. 4. Geographic pattern of ground-glass opacity in a 
patient with subacute hypersensitivity pneumonitis. Lobular 
low attenuation is also demonstrated in left upper lobe 
(arrow). 
may be demonstrated as lobular low attenuation on 
expiratory CT (Fig. 5) [21, 221. Chronic stage of HP is 
characterized by the presence of fibrosis [23, 24]. Since it 
is demonstrated as honeycombing or reticular opacities, it 
can not be distinguished from UIP on HRCT (Fig. 6). 
 Bronchiolitis obliterans organizing pneumonia (BOOP ) 
is sometimes associated with centrilobular nodules [141. 
Centrilobular nodules mainly indicate cellular infiltration 
in the bronchiolar wall. Patchy consolidation commonly
2) Interlobular septal thickening within ground-glass 
  opacity 
 Interlobular septal thickening may correspond to the 
fibrosis in perilobular region in idiopathic pulmonary 
fibrosis (IPF) or chronic interstitial pneumonia (e.g. UIP) 
[25]. Lung distortion, volume loss, honeycombing, and 
traction bronchiectasis are generally associated in these 
disorders. 
 This pattern without structural alterations are often 
seen in pulmonary alveolar proteinosis and pulmonary 
edema. Pulmonary alveolar proteinosis is a disease charac-
terized by filling of alveolar spaces with a PAS-positive 
proteinaceous material, rich in lipid. A geographic distri-
bution of ground-glass opacity and/or consolidation is 
demonstrated on HRCT. Smooth thickening of interlobu-
lar septa is superimposed and present only within areas of 
ground-glass opacity (Fig. 7) [26]. This finding on HRCT 
is well known as 'crazy-paving' appearance, reflecting 
interlobular septal edema and interstitial accumulation of 
the proteinaceous materials [27]. Crazy-paving appear-
ance can be seen in other disorders, including 
bronchioloalveolar carcinoma [28], pulmonary hemor-
rhage, and Pneumocystis carinii and cytomegalovirus 
infection.
Fig. 5. Subacute hypersensitivity pneumonitis. 
A. HRCT on deep inspiration : Faint ground-glass opacity is seen in left lower lobe. Relatively low attenuation area (LAA) of 
lobular units is demonstrated (arrow). 
B. HRCT on deep expiration : Relatively LAA on inspiratory scan remains low attenuation (arrow). This finding suggests 
focal air trapping due to obstructive change of small airway. Other lung fields heterogeneously increase lung density, which 
may reflect parenchymal abnormalities such as alveolitis or normal lung parenchyma.
Fig. 6. Suspected chronic hypersensitivity pneumonitis. 
HRCT shows diffuse ground-glass opacity associated with 
small cystic air-spaces (honeycombing) and traction 
bronchiectasis (arrows). Diffuse ground-glass opacity may 
reflect alveolitis or fibrosis, and honeycombing and traction 
bronchiectasis may indicate pulmonary fibrosis.
Fig. 8. Suspected idiopathic pulmonary fibrosis (pathologi-
cally UIP). 
HRCT shows ground-glass opacity associated with honey-
combing in peripheral predominance.
Fig. 7. Crazy-paving appearance in a patient with pulmo-
nary alveolar proteinosis. 
Linear opacities indicating interlobular and intralobular 
septal thickening is depicted within areas of ground-glass 
opacity.
Fig. 9. UIP associated with rheumatoid arthritis. 
Diffuse ground-glass opacity and reticular opacities are seen 
on HRCT. Diffuse ground-glass opacity may reflects fibrosis 
or/and alveolitis. However, it should be considered as 
fibrosis, because it is combined with traction bronchiectasis.
3) Cystic air-spaces with ground-glass opacity 
 This HRCT pattern is generally seen in chronic intersti-
tial pneumonia or IPF (Fig. 8). Cystic air-spaces in these 
disorders are generally honeycomb cysts (honeycombing). 
UIP is the most common type of chronic interstitial 
pneumonia or IPF. UIP can be seen in patients with other 
diseases, particularly collagen-vascular diseases (Fig. 9) 
such as rheumatoid arthritis and progressive systemic 
sclerosis, and certain drug reactions (e.g. from bleomy-
cin). 
 The early stage of UIP is characterized histologically by 
alveolitis and increased cellularity of alveolar wall. 
Ground-glass opacity may be demonstrated as only HRCT 
finding corresponding to these pathological changes. But 
this process progresses to fibrosis. Histopathologically, 
one lung specimen in patients with UIP may have the 
changes of various stages, from normal lung parenchyma 
and alveolitis to fibrosis (so called `temporal heterogene-
ity'). Therefore, ground-glass opacity is commonly associ-
ated with honeycombing and reticular opacities. Reticular 
opacities on HRCT correspond to areas of irregular 
fibrosis with a predominance of perilobular region, honey-
combing, and traction bronchiectasis. Lung changes 
frequently show a peripheral, subpleural, and basal pre-
dominance. Areas of ground-glass opacity also usually 
predominate in the subpleural region. 
 Ground-glass opacity on HRCT usually indicates the 
presence of disease activity and potentially treatable 
disease [29, 30], but can also be seen in the presence of
fibrosis or honeycombing below the resolution of HRCT 
(Fig. 9). However, ground-glass opacity should be consid-
ered to represent an active process (alveolitis) only when 
there are no findings of fibrosis on HRCT. Definitive 
findings of fibrosis on HRCT are traction bronchiectasis 
and honeycombing. 
 Most patients with UIP show slow progression, but 
accelerated deterioration (acute exacerbation) may also 
occur (Fig. 10). Pathologically, this condition represents 
diffuse alvelar damage (DAD) or active fibroblastic foci 
[31]. DAD is a pathologic diagnosis in most patients with 
the clinical diagnosis of adult respiratory distress syn-
drome. Acute interstitial pneumonia (AIP) also shows the 
pathological findings of DAD [32]. Therefore, the findings 
of acute deterioration of UIP and AIP are essentially 
similar on HRCT. DAD is pathologically classified into 
three phases ; exudative (or acute) phase, proliferative (or 
organizing) phase, and f ibrotic phase [331. Characteristic 
findings on HRCT are diffuse and symmetrical ground-
glass opacity and/or consolidation. They are sharply 
demarcated by relatively spared areas. Traction bro-
nchiectasis is associated with ground-glass opacity and/or 
consolidation in proliferative or fibrotic phase of DAD 
[34]. However, honeycombing is a rare finding in patients 
with AIP. In patients with accelerated deterioration of 
UIP, honeycombing is commonly combined with ground-
glass opacity. The patients with AIP and accelerated 
deterioration of UIP should be treated by high-dose 
corticosteroid therapy and are generally mortal without 
any therapies.
Fig. 10 A, B. Accelerated deterioration of UIP associated with rheumatoid arthritis. She had progressive dyspnea, dry cough, 
and fever. Chest radiograph revealed diffuse infiltrates. HRCT demonstrates sharply demarcated areas of ground-glass 
opacity with segmental or panlobular distribution. Focal spared areas of lobular units are seen in right lower lobe (arrows). 
Traction bronchiectasis and honeycombing are depicted within ground-glass opacity. Despite high-dose corticosteroid 
therapy, she died due to respiratory failure after two weeks.
 Ground-glass opacity combined with honeycombing is 
also seen in many end-stage lungs such as chronic HP (Fig. 
6), sarcoidosis, Langerhans cell histiocytosis (eosinophilic 
granuloma), and asbestosis.
Ground-Glass Opacity in Infectious Lung Disease 
 Ground-glass opacity in infectious lung disease is 
generally considered to represent mild to moderate alveo-
lar filling [3]. When alveoli become completely airless, it 
leads to air-space consolidation. Ground-glass opacity is 
also seen in resolving stage of pneumonia. 
 Radiographic and pathologic findings vary by types of 
pneumonia, namely, bacterial pneumonia and atypical 
pneumonia. Because atypical pneumonia often shows 
bilateral diffuse shadows mimicking other acute or 
subacute infiltrative lung diseases, it must be considered 
as a possibility when diagnosing those diseases. Atypical 
pneumonia includes Mycoplasma pneumonia, Chlamydia 
psittaci or pneumoniae pneumonia, Pneumocystis carinii 
pneumonia (PCP), viral pneumonia (influenza virus, 
cytomegalovirus), and so on. 
 In Mycoplasma pneumonia, the target organ is regarded 
to be the ciliated cells of respiratory tract, and pathologic 
changes are usually confirmed to the areas of bronchiolar 
and peribronchilolar regions. Therefore, ground-glass 
opacity or consolidation tends to extend with lobular 
distribution and to be combined with thickening of the 
bronchovascular bandles, and centrilobular nodular opaci-
ties [35]. 
 Chlamydia psittaci and Chlamydia pneumoniae cause 
bronchitis and pneumonia in adults. In pulmonary infec-
tion caused by chlamidia, typical pathologic changes were
Fig. 11. Chlamydia pneumoniae pneumonia. 
Patchy ground-glass opacities with bronchicentric distribu-
tion are demonstrated on HRCT.
Fig. 12. Pneumocystis carinii pneumonia associated 
with AIDS patient. 
Diffuse ground-glass opacity with focal spared areas is seen 
in bilateral lungs.
reported to arise primarily from the respiratory bronchi-
ole and then spread centrifugally to the adjacent alveoli. 
The changes never arise from the distal portion of alveolar 
ducts, atria, and alveoli, resulting in pneumonia that is 
anatomically lobular [36]. CT findings of Chlamydia 
psittaci pneumonia are reported to be seen centrilobular 
nodules and consolidation with lobular distribution [351. 
These opacities may migrate and slowly regress [36, 371. 
Chlamydia pneumoniae pneumonia (Fig. 11) has been 
described as a milder atypical pneumonia than Chlamydia 
psittaci pneumonia [38] . 
 Immunocompromised patients have an increased risk for 
developing PCP, especially patients with acquired immu-
nodeficiency syndrome (AIDS), those with lymphopro-
liferative disorders, and organ transplant recipients [39]. 
CT shows ground-glass opacities in most patients with 
PCP (Fig. 12) [40, 41]. Ground-glass opacity may form a 
geographic pattern involving secondary lobules while 
sparing others. Thickened interlobular septa within the 
areas of ground-glass opacity may be also identified in 
PCP [41]. Thin-walled cystic spaces are sometimes seen in 
AIDS patients [40]. Pneumocystis carinii infects the 
alveoli and results in lymphocytic infiltration and edema 
of the interstitium. Histopathologic features of PCP 
probably contribute to ground-glass opacity : the nature 
of fluid present within alveoli, which is foamy in appear-
ance and is known to consist of surfactant, fibrin, and 
cellular debris ; and thickening of alveolar interstitium by 
edema and cellular infiltrates [42]. 
 Immunocompromised patients also have an increased 
risk for developing cytomegalovirus (CMV) pneumonia. 
CT findings of CMV pneumonia are reported that the 
most common pattern includes small nodules and consoli-
dation. Ground-glass opacities are also identified in some 
patients, and histologically have early changes of DAD 
1431.
Ground-Glass Opacity of Hemodynamic Origin 
  Blood in the pulmonary capillary bed is a major con-
tributor to lung density. Alterations in regional blood 
flow affect lung density by increasing or decreasing blood 
volume in the capillary bed [5]. Therefore, adjacent areas 
of hyperperfused and hypoperfused lung have some degree 
of attenuation difference in most cases, referred to as 
`mosaic oligemia' or `mosaic perfusion' [5
, 12]. The 
presence of increased vascular diameters through the 
abnormal lung density will help identify ground-glass 
opacity of hemodynamic origin [3]. 
1) Chronic obstructive pulmonary disease 
  and airway disease 
 Regional blood flow in the affected areas of chronic 
obstructive pulmonary disease (COPD) and airway disease 
decreases due to vascular smooth muscle contraction and/ 
or structural changes in vessel wall [44]. If large areas of 
pulmonary vascular bed are narrowed or occluded, there 
must be a reciprocal increase in blood flow to the remain-
ing vascular patent areas to maintain the cardiac output 
[5, 44]. Ground-glass opacity may reflects a regional 
increased blood flow. Destruction of alveolar wall occurs 
in pulmonary emphysema and obstructive change of 
bronchioles occurs in small airway diseases such as con-
strictive bronchiolitis (obliterative bronchiolitis) (Fig. 
13). Ground-glass opacity with prominent vascular struc-
tures is often sharply demarcated with lobular borders in 
patients with constrictive bronchiolitis. Decreased lung 
density occurs as the result of the overinflation caused by 
emn)hvsema and air trannine'. Thus. the chane'e of lone
Fig. 13. Constrictive bronchiolitis in an allograft bone 
marrow trasplant recipient. 
Sharply demarcated areas of ground-glass opacity with 
panlobular distribution are demonstrated on HRCT. 
Presumably, decreased attenuated areas reflect air trapping 
due to obliterative change of bronchioles and areas of 
ground-glass opacity indicate regional increased blood flow 
due to redistribution (mosaic perfusion).
density may appear with higher contrast between 
nonaffected (hyperperfused) areas and affected (hypoper-
fused and overinflated) areas on CT. The differentiation 
between affected and nonaffected areas may be revealed by 
expiratory scans, because increase of lung density and loss 
of volume do not usually occur in the affected areas and 
these changes occur in the spared areas on expiration [8]. 
2) Vascular lung disease 
  Regional alteration of pulmonary blood flow secondary 
to chronic thromboembolic diseases causes increased lung 
density. Ground-glass opacity with prominent vascular 
structures is often sharply demarcated with lobular 
borders [6]. A mosaic pattern of lung density is demon-
strated with geographic areas of low density without 
evidence of emphysema or lung destruction. Low density 
areas probably reflect hypoperfused areas caused by 
thromboembolism. Therefore, these low density areas 
usually show increase of lung density as well as areas of 
ground-glass opacity on expiratory CT [8]. By another 
proposition, increased lung density may occur in occluded 
areas caused by the development of systemic collateral 
supply as antegrade systemic-to-pulmonary arterial 
shunts [45]. 
 Similar CT findings may be also demonstrated in a 
patient with Takayasu arteritis caused by involvement of 
pulmonary artery [46]. In primary pulmonary hyperten-
sion [3] and pulmonary venoocculusive disease [47], 
sharply demarcated areas of ground-glass opacity are also 
seen due to redistribution of blood flow. 
3) Pulmonary edema of cardiac origin 
 Ground-glass opacity is seen in a patient with pulmo-
nary edema. Pulmonary edema is the consequence of high 
pulmonary capillary and venous pressure due to failure of 
the left side of the heart. Fluid may locate in the alveolar 
spaces or may be restricted to the interstitium of the lung. 
HRCT findings of pulmonary edema are thickening of 
interlobular septa and peribronchiolar interstitium, and 
featureless or sharply demarcated areas of ground-glass 
opacity [48]. These findings reflect pulmonary extra-
vascular lung water either in the interstitium or alveolar 
spaces. There may also be dilated vessels through the 
abnormal lung density due to hemodynamic changes [3]. 
The sequence of fluid accumulation in lung as all or none, 
with the pattern of reaction of each individual alveolus 
being stereotyped as either air-filled and expanded or 
fluid-filled and collapsed [491. The distribution of 
parenchymal abnormalities is usually bilateral and sym-
metrical.
Fig. 14 A, B 
A : window width/window level (500HU/-900HU) 
B : window width/window level (1500HU/-750HU) 
Mimicking of ground-glass opacity on narrow window width and low window level. Thickening of vessels and bronchial walls 
are also seen in Fig. A. Multiple cystic air-spaces indicating centrilobular emphysema and small nodules are depicted.
Pitfalls in Ground-Glass Pattern Recognition 
1) Technical pitfalls 
 Varing window widths and levels greatly affect the 
interpretation of CT images. Reducing the window width 
or level may result in the mimicking of ground-glass 
opacity in pulmonary parenchyma (Fig. 14) [1, 50]. 
Thickening of vascular and bronchial walls are also seen. 
Window widths of 1500-2000 HU and window levels of 
- 700 - 750 HU are recommended , when ground-glass 
opacity is evaluated. 
2) Pitfalls by patient-related artifacts 
 Because atelectasis frequently develops in depending 
lung region, band-like areas of ground-glass opacity are 
seen in subpleural region of bilateral dorsal regions at 
supine position. Subpleural linear opacities may be also 
combined. Distinguishing reversible dependent atelectasis 
from true lesion is easily made by the scan at prone 
position. Respiratory and cardiac motion may also pro-
duce ground-glass opacity. Respiratory motion during 
acquisition of a scan usually causes patchy areas of 
ground-glass opacity throughout lung parenchyma. 
Because low lung volume results in increased lung density, 
ground-glass opacity may be demonstrated on scans 
obtained without deep inspiration (Fig. 15). These areas of 
ground-glass opacity may be diffuse or patchy in distribu-
tion [50] .
Fig. 15. Ground-glass opacity is demonstrated on scans 
obtained without deep inspiration. Ground-glass opacity is 
diffuse, but predominantly distributes in dependent portion 
of each lobes.
Conclusion 
 We reviewed ground-glass opacity on HRCT based on the 
various conditions of lung parenchyma. Evaluation of 
ground-glass opacity on HRCT is useful in the differential 
diagnosis of diseases that can produce this finding, and in 
the assessment of disease activity.
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